Faculty of Pharmacy researchers climb the Top 2% Scientists ranking

Stanford/Elsevier has published this year’s Top 2% Scientists ranking, which includes several researchers from the Faculty of Pharmacy. We congratulate Christian Benedict, Christel Bergström, Albert Mihranyan, Hanna Karlsson and several other colleagues on their prominent positions among the world’s most highly cited researchers.
In April 2026, Uppsala University rose to 24th place in Pharmacy and Pharmacology in the QS World University Rankings – a historic climb of 23 places. Now Stanford/Elsevier has published this year’s Top 2% Scientists, highlighting researchers with significant scientific impact and featuring a number of members of the Faculty of Pharmacy.

“A welcome recognition of our faculty’s global impact” • Anja Sandström
“This is a welcome recognition of the global impact of our faculty’s work. Our results are built on long-term investment, strong research environments and the ability to attract and develop outstanding researchers. Seeing our colleagues recognised internationally is a source of both pride and inspiration as we continue our efforts to strengthen Uppsala’s position in the pharmaceutical sciences,” says Dean Anja Sandström.
Among the faculty’s highest-ranked researchers are Per Artursson, whose research on drug absorption still influences the development of pharmaceutical formulations, and Hans Lennernäs, whose contributions to the Biopharmaceutics Classification System continue to have a major impact on the field. Also featured is Christian Benedict, Professor of Pharmacology. From his sleep laboratory in Uppsala, his pioneering studies – alongside his bestselling books Sömn, sömn, sömn and Sov dig till ett bättre liv – have helped demonstrate the central role of sleep in a sustainable lifestyle.

“Confirms the international relevance of our work” • Christian Benedict
“Our group focuses on how sleep affects metabolism and brain health. Our continued rise in the Top 2% Scientists ranking confirms the international relevance of our work and, above all, that our findings contribute to building new knowledge in a field that concerns us all,” says Christian Benedict.
Also ranked highly are Hanna Karlsson, Professor of Toxicology, and Albert Mihranyan, Professor of Pharmaceutical Technology, both of whom joined the Faculty of Pharmacy in 2025. Hanna Karlsson recently received a multi-million grant from Formas to study the immunological effects of microplastics. Albert Mihranyan currently plays a leading role in the faculty’s new initiative in regulatory science.

“A platform that provides a strong foundation” • Albert Mihranyan
“I completed my PhD in galenic pharmacy at the Faculty of Pharmacy. After several years of research in materials science, returning ‘home’ with the opportunity to bridge the two disciplines is a truly fantastic opportunity. At the intersection of the doctoral school in regulatory science, my role in SweDeliver and its close links with industry, our group has found a platform that provides a strong foundation for the future,” says Albert Mihranyan.
Christel Bergström, Professor of Molecular Pharmaceutics and Director of SweDeliver, is also making a significant impact. Her work on 3D printers for personalised medicines and a digital gut environment is attracting considerable attention. Her group’s research is also a key factor in SweDeliver’s progress towards a world-leading position in oral drug delivery.

“Strong recognition that our findings are relevant” • Christel Bergström
“Having our research cited by colleagues around the world is the strongest recognition we can receive that our findings are relevant and of high quality. It also shows that long-term commitment, taking on new challenges and working across disciplines pay off. I see our position in the Top 2% Scientists ranking as a result of the work of my research group at BMC, the outstanding international networks we have built over decades, and all the skilled colleagues I have the privilege of working with,” says Christel Bergström.
We also congratulate Mats Karlsson, Lena Friberg, Björn Wettermark, Robert Fredriksson, Margareta Hammarlund Udenaes, Ola Spjuth, Ulf Göransson, Anna Orlova, Thomas Dorlo and Victor Agmo Hernandez on being included in the Top 2% Scientists ranking, placing them among the academic world’s leading researchers.
“As Stanford/Elsevier recognises actual impact, the Top 2% Scientists list is a valuable indicator of scientific significance. These positions confirm that our researchers have a substantial international impact in their respective fields. The fact that our faculty also attracts outstanding researchers makes me confident that we have the potential to continue climbing the global rankings,” says Anja Sandström.
Facts
- Top 2% Scientists is an international, citation-based ranking that draws, among other sources, on data from Scopus. It includes researchers ranked among the top 100,000 worldwide or among the top two per cent in their discipline.
- C-score is a composite measure combining six citation-based indicators, including citations, the h-index and the researcher’s position in the author list. In the single-year ranking, citations refer to those received during the calendar year in question, regardless of when the publications appeared.
- A high position in the ranking can increase international visibility and help strengthen prospects for recruitment, collaboration and success in research funding applications.
Contact
Anja Sandström • Dean
Faculty of Pharmacy
018-471 5026, Anja.Sandstrom@ilk.uu.se
text: Magnus Alsne, photo: Mikael Wallerstedt a o